Carregant...

小细胞肺癌驱动基因研究进展

Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains dismal. Screening for the targetable driver mutations of this malignant tumor contributes to improve the therapeutic approaches and outcome. This review will report the advances on some latest driver mutations.

Guardat en:
Dades bibliogràfiques
Publicat a:Zhongguo Fei Ai Za Zhi
Format: Artigo
Idioma:Inglês
Publicat: 中国肺癌杂志编辑部 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5999810/
https://ncbi.nlm.nih.gov/pubmed/27118653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2016.04.10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!